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ABSTRACT
Background: Maternal obesity and hyperglycemia increase risk of
obesity and diabetes in offspring later in life.
Objective: We examined the relation between gestational glycemia
and prepregnancy body mass index (ppBMI) with offspring growth
in an Asian mother-offspring cohort.
Design: Pregnant mothers undertook a 75-g 2-h oral-glucose-tolerance
test at 26–28 wk of gestation. In 937 singleton offspring, #9 serial
measurements of weight and length were obtained from birth until
36 mo of age.
Results: Gestational fasting plasma glucose (FPG) was positively
associated with birth weight (B: 0.17; 95% CI: 0.10, 0.24; P ,
0.001) and birth BMI (B: 0.15; 95% CI: 0.06, 0.40; P = 0.001)
but not at$3 mo of age. In contrast, maternal ppBMI was positively
associated with birth variables and conditional growth in weight and
BMI in the first 36 mo of life. However, gestational FPG and pre-
pregnancy obesity status interacted significantly for the association
with offspring growth and overweight status in the first 36 mo of life
(P-interaction , 0.01). In nonobese mothers, each unit increase in
gestational FPG was associated with increased offspring weight
(B: 0.08; 95% CI: 0.008, 0.16; P = 0.03) and BMI (B: 0.08; 95%
CI: 0.003, 0.15; P = 0.04) as well as increased risk of overweight in
the first 36 mo of life (OR: 1.36; 95% CI: 1.10, 1.68). However, in
obese mothers, each unit increase in gestational FPG was associ-
ated with decreased offspring weight (B: 20.01; 95% CI: 20.02,
20.003) and BMI (B: 20.008; 95% CI: 20.01, 20.002) velocity
(P , 0.01 for both) and decreased risk of overweight (OR: 0.59;
95% CI: 0.41, 0.86) in the first 36 mo of life.
Conclusions: Prepregnancy adiposity was associated with offspring
growth in early childhood. Although pooled analyses showed no
demonstrable difference by 3 mo of age, there were contrasting
and opposite associations of gestational glycemia with weight and
BMI in the first 36 mo of life in offspring of nonobese and obese
mothers separately. This study was registered at clinicaltrials.gov as
NCT01174875. Am J Clin Nutr doi: 10.3945/ajcn.115.117614.
Keywords: gestational glycemia, offspring growth and body com-
position, prepregnancy obesity
INTRODUCTION
Obesity and type 2 diabetes present massive health challenges
because they have rapidly become worldwide epidemics (1).
Hence, an understanding of the pathogenesis is important to
formulate treatment and prevention strategies. Developmental
influence on obesity risk that originates from the maternal in-
trauterine environment has been put forth as one of the mech-
anisms that confer susceptibility to excessive adiposity (2). One
of the earliest evidence of developmental plasticity conferring
obesity susceptibility came from the Dutch famine study, which
studied the offspring of women who conceived during the Dutch
famine of 1944 when an embargo was placed on all food supplies
to the Netherlands (3, 4). Besides maternal nutrition during
pregnancy, maternal prepregnancy obesity and hyperglycemia
during pregnancy have been documented to be associated with
a higher birth weight of offspring (5), which carries with it an
inherently greater risk of diabetes and obesity in later life (6–8).
There has also been evidence that suggested that early postnatal
growth patterns predict subsequent adiposity and obesity risk in
childhood as described in The Quebec Longitudinal Study of
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Child Development in Canada (9) and, more recently, in the Fels
Longitudinal Study (10).
When studying pregnant women, a true BMI estimation can be
problematic because body weight increases with advancing
gestation. The Royal College of Obstetricians and Gynecologists
and the Centre for Maternal and Child Inquiries in the United
Kingdom (11) have suggested classifying a pregnant woman as
obese once BMI (in kg/m2) that is measured at the initial
booking is $30, whereas the Society of Obstetricians and Gy-
naecologists of Canada suggested that pregnant women can be
considered obese once prepregnancy BMI (ppBMI)13 is $30
(12). At present, it is unclear whether there is a specific BMI
criterion for pregnant Asian women. In addition, it is believed
that excessive exposure to increased glucose from the mother
during pregnancy may contribute to an excessive weight gain of
the offspring born to diabetic mothers (13). The influence of
gestational glycemia on early postnatal growth has been de-
scribed (14, 15) but can still be better defined, especially for
associations with the offspring growth pattern across the range
of glucose concentrations, even for women who are below the
diagnostic cutoff for gestational diabetes mellitus (GDM). In
addition, because of the paucity of existing data on prenatal
metabolic exposures and infant growth in Asian populations and
because the Asian phenotype and susceptibility toward obesity
and metabolic disease differs from that of Europeans (16), ad-
ditional studies on the relation between gestational glycemia
with offspring growth in Asian populations is merited. Thus, we
sought to examine the associations of gestational glycemia and
ppBMI in relation to birth measures and the postnatal growth of
offspring during the first 36 mo of life with the use of data from
the GUSTO (Growing Up in Singapore Towards healthy Out-
comes) study (clinicaltrials.gov; NCT01174875), which is an
Asian mother-offspring cohort study in Singapore.
METHODS
Study population
The GUSTO study has been previously described in detail
(17). Briefly, pregnant women in their first trimester were
recruited from 2 major public hospitals with obstetric services in
Singapore (i.e., the KKWomen’s and Children’s Hospital and the
National University Hospital) between June 2009 and September
2010. Women approached were Singapore citizens or permanent
residents who were of Chinese, Malay, or Indian ethnicity with
homogeneous parental ethnic backgrounds. Women who were
receiving chemotherapy, taking psychotropic drugs, or had di-
abetes mellitus were excluded. Of 3751 screened women, 2034
individuals met these criteria, and 1247 women (response rate:
61.3%) were recruited of whom 1152 women had singleton
naturally conceived pregnancies and deliveries (Supplemental
Figure 1). This study was approved by both the National Healthcare
Group Domain Specific Review Board and the SingHealth Cen-
tralized Institutional Review Board.
Assessment of gestational age
Gestational age (GA) was assessed with the use of ultraso-
nography. In all women, GA was first assessed in the first ul-
trasound dating scan during recruitment in the first trimester.
Scans were conducted in a standard manner at both hospitals by
trained ultrasonographers. GAwas reported in completed weeks.
Oral-glucose-tolerance testing
Pregnant women underwent a 2-h 75-g oral-glucose-tolerance
test after an overnight fast at 26–28 wk of gestation, and venous
plasma glucose was measured with the use of colorimetry
[Advia 2400 Chemistry system (Siemens Medical Solutions
Diagnostics) and Beckman LX20 Pro analyzer (Beckman
Coulter)]. During the study period, glucose management was
performed when mothers were diagnosed with hyperglycemia
according to WHO criteria (fasting or 2-h plasma glucose con-
centrations .7.0 or .7.8 mmol/L, respectively). Results were
communicated to health practitioners, and mothers who were
positively diagnosed were placed under a diet or insulin treat-
ment of management. Mothers with elevated fasting or 2-h
plasma glucose were subjected to the same glucose-management
protocol. Questionnaires were administered during the visit to
ascertain demographics and socioeconomic status.
Anthropometric measures
Maternal prepregnancy weight was self-reported at study
enrollment. At 26–28 wk of gestation, maternal weight and
height were measured with the use of a SECA 803 Weighing
Scale (SECA Corp.) and a SECA 213 Stadiometer (SECA
Corp.), respectively. Maternal ppBMI was calculated as self-
reported prepregnancy weight divided by the square of height.
Prepregnancy obesity was defined as ppBMI $30. Four-site
skinfold thickness measurements (triceps, biceps, subscapular,
and suprailliac) were measured in triplicates with the use of
Holtain skinfold thickness calipers (Holtain Ltd.) on the right
side of the body and recorded to the nearest 0.2 mm.
Anthropometric measurements of offspring weight and length
were obtained at birth and at 3, 6, 9, 12, 15, 18, 24, and 36 mo of
age. Infant weight from birth until 18 mo of age was measured to
the nearest gram with the use of a calibrated scale (SECA 334
Weighing Scale; SECA Corp.). At 24 and 36 mo of age, weight
was measured to the nearest gram with the use of a SECA 803
Weighing Scale. Recumbent infant length from birth to 24 mo of
age was measured from the top of the head to the soles of the feet
with the use of an infant mat (SECA 210 Mobile Measuring Mat;
SECA Corp.) to the nearest 0.1 cm. Standing height at 36 mo of
age was measured with the use of the SECA 213 Stadiometer
from the top of the participant’s head to his or her heels to the
nearest 0.1 cm. For reliability, all measurements were taken in
duplicates and averaged.
Infant feeding
Mothers were asked about infant milk feeding with the use of
questionnaires that were bases on a 24-h recall at routine house
visits when infants were 3, 6, 9, and 12 mo of age. In accordance
with WHO guidelines (18), feeding practices were classified
into exclusive, predominant, partial breastfeeding, and formula
13Abbreviations used: FPG, fasting plasma glucose; GA, gestational age;
GDM, gestational diabetes mellitus; GUSTO, Growing Up in Singapore
Towards healthy Outcomes; LME, linear mixed effects; ppBMI, prepreg-
nancy BMI; SDS, SD score; 2h-PG, 2-h postchallenge glucose.
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feeding. In our data collection, both direct breastfeeding and
expressed breast-milk intakes were classified as breastfeeding.
Statistical analysis
Descriptive statistics were reported as means 6 SDs for
continuous variables and percentages for categorical variables.
Fasting plasma glucose (FPG) and 2-h postchallenge glucose
(2h-PG) measurements were assessed as both continuous and
categorical variables divided into quartiles. For FPG, quartiles
were as follows: first,,4.1 mmol/L); second, 4.1 to,4.3 mmol/L);
third, 4.3 to ,4.6 mmol/L); and fourth, $4.6 mmol/L. For
2h-PG, quartiles were as follows: first, ,5.5 mmol/L; second,
5.5 to ,6.3 mmol/L); third (6.3 to ,7.3 mmol/L); and forth,
$7.3 mmol/L. Age- and sex-specific SD scores (SDSs) were
calculated for weight, length, and BMI at all time points with
reference to the local Singapore population (19) (Ministry of
Health Singapore, personal communication, 2015). Offspring
overweight status was defined as having BMI greater than the
85th percentile (i.e., BMI SDS .1.036). The SDS was also
produced for maternal FPG, 2h-PG, and ppBMI.
Offspring conditional growth was derived from standardized
residuals resulting from the regression of the SDS for a mea-
surement at a specific time point on the SDS for measurements at
preceding ages (20). For example, the dependent variable of
conditional growth in weight SDS from 0–3 mo of age was
derived as the residual of the regression of weight SDS at 3 mo
of age on the weight SDS at birth. Multivariable linear re-
gression analyses were used to estimate associations between
maternal glucose concentrations and ppBMI with offspring
conditional growth, in all cases with adjustment for ethnicity,
parity, maternal age, education, height at 26–28 wk of gestation,
gestational weight gain until 26–28 wk of gestation, and
breastfeeding duration. In view of mothers who received treat-
ment for hyperglycemia, we further corrected for potential
confounding by glucose management (diet and insulin treat-
ment) in the regression models. Potential effect modifications by
prepregnancy obesity status were investigated by adding the
interaction term of glucose with prepregnancy obesity status to
the fully adjusted model. Because the associations were assessed
at 9 time points for each outcome of conditional growth in
weight, length, and BMI, a more stringent cutoff of P , 0.005
was considered statistically significant, and P , 0.01 was con-
sidered as trend associations for each outcome.
In addition, we examined the longitudinal effect of glucose
concentrations on weight and BMI SDS growth trajectory with
the use of linear mixed effects (LME) models, which took into
account the correlation between repeated measures on the same
individual and allowed for incomplete outcome data with the
assumption that it was missing at random (21). Maximum
likelihood was the method of estimation used, and an un-
structured working covariance matrix for random effects
variables (intercept and slope) was chosen. The Akaike in-
formation criterion statistic facilitated the model selection, and
final models included linear, quadratic, and cubic terms for
children’s ages and age-glucose interactions to estimate the
change in weight and BMI SDS over time associated with
a unit SDS increase in glucose concentrations. Besides the
fixed effect of age, we allowed for a random intercept and
random linear slope for age. We also tested the associations of
gestational glycemia with child overweight with the use of
generalized estimating equations to model the odds of being
overweight in the first 36 mo of life longitudinally with ad-
justment for ethnicity, parity, maternal age, education, height
at 26–28 wk of gestation, gestational weight gain until 26–28 wk
of gestation, and breastfeeding duration. Similar to LME
models, generalized estimating equation models are often
used for repeated-measures data because they accounts for the
within-subject correlation between observations across time
and can allow for missing data in the outcome measure. Be-
cause growth velocities in offspring of obese and nonobese
women are different (22), separate models were constructed.
All analyses were performed with the use of Stata 13 software
(StataCorp LP).
RESULTS
Complete data on glucose concentrations and ppBMI were
available for 937 women (Supplemental Figure 1). There were no
significant differences in sociodemographic characteristics (ed-
ucation, ethnicity, marital status, and housing type) between
women included (n = 937) and excluded (n = 300) in the study
sample except for parity (P = 0.005) (Supplemental Table 1).
Characteristics of mothers included in the study sample are
shown in Table 1. Most of the mothers’ characteristics differed
significantly across ethnic groups, including maternal age (P ,
0.001), education (P , 0.001), housing type (P , 0.001), parity
(P = 0.015), ppBMI (P , 0.001), prepregnancy obesity status
(P , 0.001), gestational weight gain (P = 0.029), breastfeeding
duration (P , 0.001), FPG (P = 0.001), and 2h-PG concentra-
tions (P = 0.001) and GDM treatment type (P = 0.004). Indian
mothers reported highest glucose concentrations (P , 0.001),
whereas Malay mothers reported highest ppBMI (P , 0.001),
proportion of obesity (P , 0.001), and gestational weight gain
(P = 0.042). Chinese and Indian mothers were of higher so-
cioeconomic status (education and type of housing) than Malay
mothers were (P , 0.001 for all). Offspring characteristics also
differed significantly across ethnic groups, including birth
length and BMI (P = 0.024 and P = 0.001, respectively).
Figure 1A–C highlights the association of gestational FPG
SDS with offspring conditional growth in the first 36 mo of life.
The FPG SDS had significant positive associations with birth-
weight SDSs (B: 0.17; 95% CI: 0.10, 0.24; P, 0.001) and birth-
BMI SDSs (0.15; 95% CI: 0.06, 0.40; P = 0.001), but no
significant associations with the serial anthropometric measures
were observed from $3 mo of age after adjustment for potential
confounders. 2h-PG SDSs showed positive associations with
birth-weight SDSs only (0.07; 95% CI: 0.01, 0.15; P = 0.03)
(data not shown). In contrast, maternal ppBMI SDSs showed
a significant association with birth-weight SDSs (0.21; 95% CI:
0.14, 0.28; P , 0.001), conditional growth in weight SDSs
between 0–36 mo of age (0.09; 95% CI: 0.007, 0.17; P = 0.033)
(Figure 2A), and birth-length SDSs (0.09; 95% CI: 0.03, 0.17;
P = 0.007) (Figure 2B). Maternal ppBMI SDSs also showed
positive associations with birth-BMI SDSs (0.11; 95% CI: 0.02,
0.20; P = 0.021) and conditional growth in BMI SDSs between
0–12 mo of age (0.10; 95% CI: 0.02, 0.19; P = 0.018), 0–18 mo
of age (0.11; 95% CI: 0.01, 0.20; P = 0.024), 0–24 mo of age
(0.14; 95% CI: 0.05, 0.23; P = 0.002), and 0–36 mo of age (0.19;
95% CI: 0.10, 0.27; P , 0.001) (Figure 2C).
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We noted that gestational FPG and prepregnancy obesity status
interacted significantly for the association with offspring condi-
tional growth in weight SDSs between 0–18 mo of age (P = 0.025),
0–24 mo of age (P = 0.012) and 0–36 mo of age (P = 0.003) as
well as for the outcome of conditional growth in BMI SDSs be-
tween 0–18 mo of age (P = 0.011), 0–24 mo of age (P = 0.013),
and 0–36 mo of age (P = 0.015) (Supplemental Table 2), which
implied that the relation between gestational FPG with offspring
growth in the first 36 mo of life appears to be modified by pre-
pregnancy obesity status. In a fully adjusted LME model for
nonobese women (Figure 3A, C), we observed that, on average,
the FPG SDS was positively associated with offspring weight and
BMI SDSs across the first 36 mo of life (P = 0.03 and P = 0.04,
respectively) with every unit increase in the FPG SDS increasing
the weight SDS by 0.08 units (95% CI: 0.008, 0.16 units) and BMI
SDS by 0.08 units (95% CI: 0.003, 0.15 units). In addition, ges-
tational FPG and prepregnancy obesity status interacted signifi-
cantly for the association with offspring overweight in the first
36 mo of life (P, 0.001). In nonobese mothers, a higher FPG SDS
was associated with increased risk of being overweight in the first
36 mo of life (P = 0.001) with each unit increase in the FPG SDS
increasing the odds of offspring overweight by 36% (OR: 1.36;
95% CI: 1.10, 1.68) after adjustment for potential confounders
(Table 2). This observation might have been due to the increasing
severity in maternal adiposity at 26–28 wk of gestation across
increasing FPG in nonobese mothers (Table 3); nevertheless, the
results were still significant when adjusted for maternal adiposity
(sum of skinfold-thicknesses) at 26–28 wk of gestation (Table 2).
However, in a fully adjusted LME model for obese women
(Figure 3B, D), we noted a decrease in weight and BMI SDS
velocity across age with an increasing FPG SDS (P = 0.003 and
P = 0.009, respectively) with an estimated rate of decrease of
TABLE 1
Demographic and clinical characteristics of study subjects
Chinese Malay Indian Total P1
Mothers, n 516 252 169 937
Age, y 31.5 6 4.92 28.9 6 5.53 29.8 6 4.73 30.5 6 5.2 ,0.001
Marital status, n (%) 0.352
Married 495 (96.3) 241 (95.6) 166 (98.2) 902 (96.5)
Single 19 (3.7) 11 (4.4) 3 (1.8) 35 (3.5)
Years of education, n (%) ,0.001
,12 155 (30.0) 174 (69.0) 52 (30.8) 381 (40.7)
$12 361 (70.0) 78 (31.0)3 117 (69.2) 556 (59.3)
Type of housing, n (%) ,0.001
Government 457 (88.6) 250 (99.2) 154 (91.1) 861 (91.9)
Private 59 (11.4) 2 (0.8)3 15 (8.9) 76 (8.1)
Breastfeeding duration, n (%) ,0.001
Formula only 71 (14.8) 49 (21.6) 23 (14.9) 143 (16.6)
,4 mo 279 (58.0) 156 (68.7) 97 (63.0) 532 (61.7)
$4 mo 131 (27.2) 22 (9.7)3 34 (22.1) 187 (21.7)
Parity, n (%) 0.015
Primiparous 243 (47.8) 101 (40.9) 60 (35.9) 404 (43.8)
Multiparous 265 (52.2) 146 (59.1) 107 (64.1)3 518 (56.2)
Prepregnancy obesity, n (%) ,0.001
Nonobese (,30 kg/m2) 502 (97.3) 215 (85.3) 154 (91.1) 871 (93.0)
Obese ($30 kg/m2) 14 (2.7) 37 (14.7)3 15 (8.9)3 66 (7.0)
Prepregnancy BMI, kg/m2 21.5 6 3.3 24.2 6 5.53 23.8 6 4.43 22.7 6 4.4 ,0.001
Gestational weight gain until 26–28 wk, kg 8.5 6 3.7 9.2 6 5.83 8.0 6 4.5 8.6 6 4.5 0.029
Plasma glucose, mmol/L
Fasting 4.3 6 0.4 4.3 6 0.5 4.5 6 0.53 4.3 6 0.5 0.001
2 h 6.6 6 1.4 6.2 6 1.53 6.6 6 1.6 6.5 6 1.5 0.001
GDM treatment type, n (%) 0.004
No 409 (80.0) 222 (90.2) 130 (77.8) 761 (82.4)
Diet treatment 95 (18.6) 21 (8.5)3 34 (20.4) 150 (16.2)
Insulin treatment 7 (1.4) 3 (1.2) 3 (1.8) 13 (1.4)
Offspring
Gestational age at delivery, wk 38.3 6 1.5 38.2 6 1.3 38.2 6 1.5 38.3 6 1.5 0.182
Sex, n (%) 0.684
M 248 (48.4) 112 (45.2) 81 (48.2) 441 (47.5)
F 264 (51.6) 136 (54.8) 87 (51.8) 487 (52.5)
Birth weight, kg 3.1 6 0.5 3.1 6 0.4 3.0 6 0.5 3.1 6 0.5 0.145
Birth length, cm 48.8 6 2.3 48.3 6 2.03 48.6 6 2.2 48.6 6 2.3 0.024
Birth BMI, kg/m2 13.0 6 1.3 13.3 6 1.33 12.8 6 1.4 13.0 6 1.3 0.001
1P values across 3 ethnic groups were determined with the use of a chi-square analysis (categorical) or 1-factor
ANOVA (continuous). GDM, gestational diabetes mellitus.
2Mean 6 SD (all such values).
3P , 0.05 compared with Chinese [determined with the use of a chi-square analysis (categorical) or 2-sample t test
(continuous)].
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0.01 weight SDS units/mo (95% CI:20.02,20.003 weight SDS
units/mo) and 0.008 BMI SDS units/mo (95% CI: 20.01,
20.002 BMI SDS units/mo) for every unit SDS increase in FPG.
Furthermore, an increasing FPG SDS was associated with de-
creased risk of being overweight in the first 36 mo of life with
each unit increase in the FPG SDS decreasing the odds of off-
spring overweight by 41% (OR: 0.59; 95% CI: 0.41, 0.86)
(Table 2). This reverse pattern might have been due to differ-
ences in adiposity severity at 26–28 wk of gestation, the ethnic
distribution, and the breastfeeding duration across FPG quar-
tiles, but we did not find any significant differences of these
factors (Table 3).
We conducted additional sensitivity analyses by restricting
the analyses to mothers without GDM (n = 763). In a fully
adjusted LME model for nonobese, non-GDM women (n =
717), we observed that, on average, the FPG SDS was posi-
tively associated with offspring weight and the BMI SDS
across the first 36 mo of life (P = 0.029 and P = 0.017, re-
spectively),with every unit increase in the FPG SDS in-
creasing the weight SDS by 0.10 units (95% CI: 0.01, 0.20
units) and the BMI SDS by 0.11 units (95% CI: 0.02, 0.20
units) (Supplemental Figure2A, C). However, in a fully ad-
justed LME model for obese, non-GDM women (n = 46), we
noted a decrease in BMI SDS velocity across age with an
increasing FPG SDS (P = 0.044) with an estimated rate of
decrease of 0.009 BMI SDS units/mo (95% CI:20.02,20.002 BMI
SDS units/mo) for every unit SDS increase in FPG (Supplemental
Figure 2D).
FIGURE 1 Associations (regression coefficients 6 95% CIs) between
maternal FPG SDSs at 26–28 wk of gestation with offspring conditional
growth in weight SDSs (A), length SDSs (B), and BMI SDSs (C) in the first
36 mo of life. All models were analyzed with the use of multivariable linear
regression with adjustment for ethnicity, parity, maternal age, maternal ed-
ucation, prepregnancy BMI, gestational weight gain until 26–28 wk of age,
gestational diabetes mellitus treatment type, and breastfeeding duration.
****P , 0.001. FPG, fasting plasma glucose; SDS, SD score.
FIGURE 2 Associations (regression coefficients 6 95% CIs) between
maternal ppBMI SDSs with offspring conditional growth in in weight SDSs
(A), length SDSs (B), and BMI SDSs (C) in the first 36 mo of life. All
models were analyzed with the use of multivariable linear regression with
adjustment for ethnicity, parity, maternal age, maternal education, prepreg-
nancy BMI, gestational weight gain until 26–28 wk, gestational diabetes
mellitus treatment type, and breastfeeding duration. Data are shown as re-
gression coefficient 6 95% confidence intervals. *P , 0.05, **P , 0.01,
****P , 0.001. ppBMI, prepregnancy BMI; SDS, SD score.
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DISCUSSION
In summary, this study highlights the associations between
gestational glycemia and prepregnancy adiposity with offspring
growth in an Asian population. Consistent with earlier studies
(23, 24), we showed that gestational FPG was significantly as-
sociated with anthropometric variables at birth and was most
pronounced in mothers with higher FPG, whereas 2h-PG had
minimal associations with growth except at birth. In addition, we
showed that, in all mothers, the association of gestational gly-
cemia on offspring growth had no demonstrable difference by
3 mo of age in contrast with ppBMI, which was associated with
offspring weight and BMI in first 36 mo of life. Note that the
associations for gestational FPG and ppBMI were assessed across
9 time points for each outcome of conditional growth in weight,
length, and BMI and, therefore, increased the possibility of
chance findings. However, our results satisfied stringent cutoffs of
significance, suggesting that the observations were unlikely due
to chance.
These findings are in line with those of previous studies (25)
that have documented the disappearance of the association be-
tween maternal glycemia with offspring growth by 3 mo of age
but a persistent association between maternal BMI with off-
spring weight and BMI, but not length, in the first 2 y of life.
Earlier findings (26, 27) have also documented the age-associated
disappearance of the association between maternal glycemia
and higher child weight status at early childhood ages, and its
reemergence at only school-going age, which suggested that
maternal FPG in relation to subsequent higher offspring adi-
posity might start beyond 3 y of age. The positive relation
between maternal BMI on offspring size and adiposity has been
a well-observed phenomenon (28, 29), and there may be dif-
ferent pathways that underlie the associations between maternal
BMI and postnatal growth. First, shared familial characteristics,
such as socioeconomic status, may have influenced our results.
Although we controlled for the in utero and present environment
of offspring by taking maternal sociodemographic characteris-
tics into account, we could not rule out the possibility of residual
confounding. Breastfeeding could also be an important factor
that contributes to the association of ppBMI and offspring
growth. Higher maternal BMI is generally associated with
shorter durations of breastfeeding (30), and breastfed children
tend to grow more slowly than do formula-fed peers (31, 32).
FIGURE 3 Offspring weight and BMI SDS trajectory in the first 36 mo of life shown according to categories of fasting glucose measured at 26–28 wk of
gestation in offspring of nonobese women (A and C) and obese women (B and D). All the models were analyzed with the use of linear mixed-effects
regression with adjustment for ethnicity, parity, maternal age, maternal education, prepregnancy BMI, gestational weight gain until 26–28 wk, gestational
diabetes mellitus treatment type, and breastfeeding duration. FPG categories were as follows: first quartile, ,4.1 mmol/L; second quartile, 4.1 to ,4.3 mmol/L;
third quartile, 4.3 to ,4.6 mmol/L, and fourth quartile, $4.6 mmol/L. FPG, fasting plasma glucose; SDS, SD score.
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Therefore, children from obese mothers could grow faster
because of reduced breastfeeding. In the current study, ad-
justment for breastfeeding duration did not change the signif-
icant associations between ppBMI with offspring growth. Thus,
our results are suggestive that ppBMI has a greater influence on
childhood growth and adiposity and provide support for ma-
ternal adiposity as a strong correlate of childhood growth
compared with gestational glycemia in Asian mothers and
offspring.
Our findings highlighted that gestational FPG and prepreg-
nancy obesity status interacted significantly for the association
with offspring conditional growth and overweight status in the
first 36 mo of life, which implies that the relation between
gestational FPG with offspring growth and adiposity appears to
be modified by prepregnancy obesity status. Although pooled
analyses showed no demonstrable differences by 3 mo of age,
we showed contrasting and opposite associations between ges-
tational glycemia with growth and adiposity in offspring of
TABLE 2
Estimated odds of child overweight in the first 36 mo of life by longitudinal logistic regression with the use of a GEE
model according to maternal FPG SDSs and other covariates1
Nonobese mothers
(n = 871)
Obese mothers
(n = 66)
P-interactionOR (95% CI) P OR (95% CI) P
FPG SDS 3 prepregnancy obesity — — — — 0.00006
FPG SDS per unit SD increase 1.36 (1.10, 1.68) 0.005 0.59 (0.41, 0.86) 0.005 —
Maternal age per year increase 1.04 (1.00, 1.08) 0.050 1.08 (0.93, 1.26) 0.324 —
$12 y vs. ,12 y of education 0.76 (0.50, 1.16) 0.204 0.25 (0.07, 0.90) 0.034 —
Malay vs. Chinese 2.81 (1.77, 4.46) ,0.001 0.49 (0.13, 1.82) 0.288 —
Indian vs. Chinese 1.80 (1.06, 3.03) 0.028 0.43 (0.04, 4.55) 0.483 —
GDM diet treatment vs. non-GDM 0.59 (0.32, 1.10) 0.094 0.62 (0.15, 2.58) 0.513 —
GDM insulin treatment vs. non-GDM 1.17 (0.29, 4.81) 0.828 —2 — —
Multiparity vs. primiparity 0.70 (0.46, 1.08) 0.108 0.53 (0.11, 2.46) 0.415 —
Gestational weight gain per kilogram increase 1.05 (1.01, 1.10) 0.010 1.11 (0.99, 1.23) 0.059 —
Maternal sum of skinfold thicknesses per
millimeter increase
1.01 (0.99, 1.02) 0.269 0.98 (0.94, 1.02) 0.354 —
Breastfeeding duration per month increase 1.00 (0.97, 1.04) 0.935 1.02 (0.94, 1.12) 0.631 —
Child age per year increase 1.04 (0.90, 1.21) 0.597 1.48 (0.86, 2.56) 0.158 —
1ORs represents the odds of being overweight in the first 36 mo of life. FPG, fasting plasma glucose; GDM, gestational
diabetes mellitus; GEE, generalized estimating equation; SDS, SD score.
2OR could not be calculated because there were no obese subjects who were receiving GDM insulin treatment.
TABLE 3
Differences in maternal adiposity (skinfold thickness) severity at 26–28 wk of gestation, breastfeeding duration, and ethnic distribution across FPG quartiles
stratified by prepregnancy obesity status1
Nonobese mothers, FPG quartiles
(n = 871)
Obese mothers, FPG quartiles
(n = 66)
P-interaction
First
(n = 218)
Second
(n = 190)
Third
(n = 247)
Fourth
(n = 216) P2
First
(n = 15)
Second
(n = 7)
Third
(n = 15)
Fourth
(n = 29) P2
Triceps skinfold
thickness, mm
19.9 6 5.43 21.0 6 5.3 21.9 6 5.6 23.8 (5.3) ,0.001 27.2 6 5.2 31.7 6 3.8 29.4 6 3.7 30.2 6 5.4 0.151 0.353
Biceps skinfold
thickness, mm
10.1 6 4.2 10.6 6 4.3 11.9 6 4.9 12.6 6 4.9 ,0.001 18.3 6 6.5 18.7 6 4.4 18.9 6 3.9 19.9 6 5.0 0.784 0.892
Subscapular skinfold
thickness, mm
19.8 6 6.3 20.5 6 6.0 21.3 6 5.9 23.1 6 5.6 ,0.001 28.1 6 6.5 31.2 6 5.2 29.5 6 3.5 31.0 6 4.2 0.261 0.750
Suprailliac skinfold
thickness, mm
22.9 6 5.7 22.6 6 5.6 23.2 6 5.1 25.0 6 5.3 ,0.001 28.4 6 5.7 28.6 6 0.4 29.0 6 4.6 29.4 6 4.2 0.920 0.891
Breastfeeding duration, n (%) 0.386 0.724 0.362
Formula only 36 (27.9) 18 (14.0) 39 (30.2) 36 (27.9) 3 (21.4) 3 (21.4) 2 (14.3) 6 (42.9)
,4 mo 107 (25.7) 91 (21.8) 114 (27.3) 105 (25.2) 9 (27.3) 3 (9.1) 8 (24.2) 13 (39.4)
.4 mo 64 (24.7) 65 (25.1) 68 (26.3) 62 (23.9) 3 (27.3) 0 (0) (27.3) 5 (45.5)
Ethnicity, n (%) 0.079 0.333 0.485
Chinese 124 (24.7) 118 (23.5) 148 (29.5) 112 (22.3) 2 (14.3) 1 (7.1) 4 (28.6) 7 (50.0)
Malay 62 (28.8) 45 (20.9) 56 (26.0) 52 (24.2) 11 (29.7) 6 (16.2) 7 (18.9) 13 (35.1)
Indian 32 (20.8) 27 (17.5) 43 (27.9) 52 (33.8) 2 (13.3) 0 (0.0) 4 (26.7) 9 (60.0)
1FPG categories were as follows: first quartile, ,4.1 mmol/L; second quartile, 4.1 to ,4.3 mmol/L; third quartile, 4.3 to ,4.6 mmol/L, and fourth
quartile, $4.6 mmol/L. FPG, fasting plasma glucose.
2P values across FPG quartiles were determined with the use of a chi-square analysis (categorical) or 1-factor ANOVA (continuous).
3Mean 6 SD (all such values).
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nonobese and obese mothers when analyzed separately. Although
raised FPG was associated with increased weight, BMI, and risk
of overweight in offspring of nonobese women in our cohort, we
observed that an increasing FPGwas associated with a decreasing
weight and BMI velocity over time as well as decreasing risk of
overweight in offspring of obese women (Figure 3A–D), and
similar observations were noted when analyses were restricted
to non-GDM mothers only (Supplemental Figure 2A–D). These
opposing associations could have been ameliorated when all
mothers were included, thereby explaining our observations in
the pooled analyses.
Our observations in nonobese mothers might have been due to
the increasing severity in maternal adiposity at 26–28 wk of
gestation across FPG quartiles in the study sample. However,
our analyses were adjusted for maternal skinfold thickness,
which indicated that the observed association was independent
of maternal adiposity. Nonetheless, our results were consistent
with findings by Ehrlich et al. (33). It is plausible that the effects
of FPG during pregnancy would be easier to detect in offspring
of nonobese women (22). The exposure to increased maternal
glycemia has been associated with increased fetal hyper-
insulinemia (34) and neonatal adiposity (5). The third trimester
of pregnancy is also a sensitive period for adipose cell hyper-
plasia in mothers (35); thus, increased maternal glucose may
further result in fetal exposure to increased lipid substrates
during this critical period (36).
However, our observations in obese mothers were not
explained by differences in adiposity severity at 26–28 wk of
gestation. When a relation between raised gestational FPG with
offspring growth was considered, is it necessary to consider
potential differences in postnatal behaviors such as breastfeed-
ing. Nevertheless, we observed no differences in breastfeeding
duration or ethnic distribution across FPG quartiles in obese
mothers in our study sample. Ehrlich et al. (33) similarly showed
that there was a negative association between increasing preg-
nancy glucose and the offspring BMI z score in the first 3.5 y of
life, and the association between increasing pregnancy glucose
with an increased BMI z score in obese mothers attained near
significance only at 7 y of age. Although the mechanism for
these effects is still unknown, the result again suggests that, in
obese mothers, the relation between maternal FPG with sub-
sequent higher offspring adiposity might start only beyond 3 y of
age.
The prospective design of our cohort was a clear strength in
our study because it was crucial for the examination of the effect
of in utero exposure on the outcome of offspring growth and
adiposity. To date, there are a paucity of existing data on
prenatal metabolic exposures and infant growth in Asian
populations; thus, our study provides useful, informative data on
this relation. However, there were limitations to consider. First,
glucose data were collected only at fasting and 2 h post-
challenge but not at 1 h postchallenge. Data on 1-h glucose
would have allowed us to better address the role of gestational
glycemia with offspring growth. Second, maternal prepreg-
nancy weight was self-reported during study enrollment, which
may have subjected the data to a potential recall bias. However,
our data showed a strong correlation between recalled pre-
pregnancy weight and measured weight at 26–28 wk of ges-
tation (r = 0.923), which indicated the high reliability of the
use of prepregnancy weight and BMI measures in this study.
Third, the relatively small sample size of this study may have
resulted in reduced power to detect interactions and certain
associations, especially in analyses restricted to obese women.
However, the analyses were conducted with the use of longi-
tudinal models that made use of repeated measurements for
each individual over a period of time, which would subse-
quently have resulted in increased power. Last, our study also
lacked measures of plasma insulin, insulin growth factors,
ghrelin, leptin, and adiponectin, which would have been useful
to mechanistically explain the observed associations between
gestational FPG and prepregnancy adiposity with offspring
weight and BMI.
In conclusion, we show that prepregnancy adiposity is asso-
ciated with offspring growth in early childhood. In addition,
although pooled analyses showed no demonstrable difference by
3 mo of age, there are contrasting and opposite associations of
gestational glycemia with weight and BMI in the first 36 mo of
life in offspring of nonobese and obese mothers separately.
Currently, children in the GUSTOwill be followed up until 9 y of
age. Future follow-up studies on these children would be essential
to evaluate if our observations have long-term repercussions in
later childhood.
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